Equities

Axim Biotechnologies Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
AXIM:PKC

Axim Biotechnologies Inc

Actions
  • Price (USD)0.011
  • Today's Change0.00 / 0.00%
  • Shares traded160.79k
  • 1 Year change+266.67%
  • Beta-0.5940
Data delayed at least 15 minutes, as of Mar 05 2026 20:53 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Thursday, Axim Biotechnologies Inc (AXIM:PKC) closed at 0.011, 279.31% above the 52 week low of 0.0029 set on Mar 17, 2025.
52-week range
Today
0.0029Mar 17 20250.0288Dec 03 2025
Open0.01
High0.0112
Low0.0084
Bid--
Offer--
Previous close0.011
Average volume74.27k
Shares outstanding332.96m
Free float258.40m
P/E (TTM)--
Market cap3.66m USD
EPS (TTM)-0.0163
USD
Data delayed at least 15 minutes, as of Mar 05 2026 20:53 GMT.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.